Direct duodenal switch achieved superior disease-free status at 5 years (66.7% vs 57.1%, p<0.001) compared to two-step approach in patients with BMI > 50 kg/m².
Does direct (one-stage) duodenal switch improve disease-free status and weight loss compared to two-step duodenal switch in patients with severe obesity?
In patients with severe obesity, direct one-stage duodenal switch achieves longer metabolic disease-free status and better weight control at 5 years compared to a two-step approach, with comparable safety.
Absolute Event Rate: 0% vs 0%
BACKGROUND: Duodenal switch (DS) can be performed as a direct one-stage procedure or as a planned/revisional two-step approach after sleeve gastrectomy. Consistent head-to-head evidence on long-term disease-free time is limited. OBJECTIVES: To compare disease-free time and safety between direct (one-stage) and two-step DS. SETTING: Spanish tertiary bariatric center. METHODS: Propensity-score matched analysis (1:1) of patients undergoing DS, comparing direct versus two-step procedures. Matching variables were age, sex, and baseline body mass index (BMI). From 429 DS cases, 75 direct DS patients were matched to 75 two-step patients. Outcomes included short- and long-term complications, mortality, severe diarrhea or malnutrition, follow-up completeness at 3 and 5 years, weight loss, BMI 50 kg/m², direct DS achieves longer high-risk disease-free status while maintaining a safety profile comparable to two-step DS.
Osorio et al. (Tue,) reported a other. Direct duodenal switch achieved superior disease-free status at 5 years (66.7% vs 57.1%, p<0.001) compared to two-step approach in patients with BMI > 50 kg/m².
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: